Keyron
Founded 2016 · 1 known investors
Keyron develops medical device and endoscopic technology for the treatment of obesity, type 2 diabetes ("diabesity"), and metabolic disease, advancing toward clinical trials and FDA approval. The company works across medical device, pharmaceutical, and diagnostics divisions in the field of GI endoscopy and metabolic surgery.
BiotechDigital HealthHealthtechMedical Devices
Founders & leadership
Keyron was founded in 2016 by Giorgio Castagneto Gissey.
GC
Giorgio Castagneto GisseyChief Executive, Chairman & Co-Founder
JP
Joyce PeetermansActing CTO
DF
David FeigalHead of Regulatory Affairs & Board Member
FR
Francesco RubinoChief Officer for Obesity and Diabetes & Board Member
CL
Carel le RouxChief Medical Officer & Director of Pharmaceutical Division
NV
Nicol VerheemChief Investment Officer, Director of Diagnostics Division & Board Member
MC
Marco CastagnetoChief Scientific Officer & Director of Medical Device Division
Board
GM
Geltrude MingroneChief Advisor
Investors · 1
Competitors · 1
by search overlap
Companies competing with Keyron for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Keyron do?
- Keyron develops medical device and endoscopic technology for the treatment of obesity, type 2 diabetes ("diabesity"), and metabolic disease, advancing toward clinical trials and FDA approval. The company works across medical device, pharmaceutical, and diagnostics divisions in the field of GI endoscopy and metabolic surgery.
- Who founded Keyron?
- Keyron was founded by Giorgio Castagneto Gissey in 2016.
- Who are Keyron's investors?
- Keyron's investors include Health Wildcatters.